A New York grand jury failed to indict the officers involved in Eric Garner’s death, while the Roberts Court heard arguments in two big cases for equality advocates.
This week, six lab-grown penises are almost ready for implantation, and an Italian couple apparently became stuck together after a tryst at the beach went awry.
If not enough women and people of color are included in clinical trials, it is not possible to determine how they’re affected by the new drug or device. And without this information women, particularly women of color, can’t make informed decisions about the medical products available.
Recently, social media lit up with the news that Amazon.com vendors are selling Plan B One-Step emergency contraception for as low as $16.90 plus shipping. We have to ask: How is that possible?
Though the FDA decision to permit generic EC pill manufacturers to sell their products over the counter represents a gain for those with the most access to resources, ultimately the decision reflects pharmaceutical manufacturing companies’ interests, rather than the lives of those most adversely affected by lack of access to EC.
Current recommendations suggest Pap tests be used as primary screening tools for cervical cancer, but some experts would like to see newer DNA testing used more often.
While there is much enthusiasm surrounding experimental new techniques that aim to help women with severely mutated mitochondrial DNA to have a child that would not inherit the disorders that can be caused by those mutations, the verdict is still out on the procedures. And it doesn’t look good.
For many years, the term “unprotected sex” has been synonymous with “sex without a condom.” But some HIV advocates argue that this language is outdated and imprecise, and the CDC has agreed to change it.
Continuing to fight science and common sense on Plan B isn’t serving anyone’s interests. Pro-choicers are mad, anti-choicers aren’t placated, and women are hurt in the process. So why does the Obama administration insist on keeping up this pointless fight?
U.S. District Court Judge Edward R. Korman today delivered a scorching critique of the Obama administration’s policies, saying that the FDA’s decision-making on EC has been corrupted by political influence.